StonvexLoading…
StonvexStonvexStonvexCore line items from CBZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.76B | $1.81B | $1.59B | $1.41B |
Operating Income | $234.01M | $73.72M | $165.24M | $168.34M |
Net Income | $115.44M | $41.04M | $120.97M | $105.35M |
EPS (Diluted) | $1.83 | $0.78 | $2.39 | $2.01 |
Total Assets | $4.41B | $4.47B | $2.04B | $1.88B |
Total Liabilities | $2.65B | $2.69B | $1.25B | $1.17B |
Cash & Equivalents | $18.29M | $13.83M | $8.09M | $4.70M |
Free Cash Flow OCF − CapEx | $175.53M | $110.78M | $130.46M | $117.49M |
Shares Outstanding | 54.38M | 50.20M | 49.81M | 50.18M |